Roche and Genentech to Invest $700M in New North Carolina Facility, Creating 1,900+ Jobs
Genentech, a member of the Roche Group, announced plans to invest more than $700 million in a new 700,000 square foot state-of-the-art drug manufacturing facility in Holly Springs, NC. The project will add more than 400 high-wage manufacturing jobs when the site is operational and more than 1,500 construction jobs d…
